{"id":2070,"date":"2026-06-12T21:56:59","date_gmt":"2026-06-12T21:56:59","guid":{"rendered":"https:\/\/euslimstore.com\/?p=2070"},"modified":"2026-06-12T21:57:55","modified_gmt":"2026-06-12T21:57:55","slug":"mounjaro-vs-wegovy-comparison-2026","status":"publish","type":"post","link":"https:\/\/euslimstore.com\/fr\/mounjaro-vs-wegovy-comparison-2026\/","title":{"rendered":"Mounjaro vs Wegovy: Which Should You Buy in 2026? (The Complete Comparison)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Updated June 2026. The definitive side-by-side comparison of the two most effective prescription weight loss medications in Europe \u2014 tirzepatide vs semaglutide \u2014 covering effectiveness, side effects, costs, contraindications, dosing schedules, cardiovascular benefits, and clinical evidence to help you choose the right treatment.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you&#8217;re considering prescription weight loss treatment in 2026, you&#8217;re almost certainly comparing <a href=\"https:\/\/euslimstore.com\/buy-mounjaro-injectable-pen\/\"><strong>Mounjaro (tirzepatide)<\/strong><\/a> against <a href=\"https:\/\/euslimstore.com\/wegovy-weight-loss-injection\/\"><strong>Wegovy (semaglutide)<\/strong><\/a>. These two medications dominate the European weight loss market \u2014 and for good reason. They produce more weight loss than any treatments before them, with safety profiles built on years of cumulative clinical data.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">But which one is right for you? The honest answer: it depends on your specific medical profile, treatment goals, budget, side effect tolerance, and whether you have certain conditions (like cardiovascular disease) where one medication has more proven benefit. This comprehensive comparison gives you everything you need to make an informed decision \u2014 or to discuss the choice intelligently with your reviewing doctor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The Headline Comparison: Mounjaro vs Wegovy at a Glance<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th><a href=\"https:\/\/euslimstore.com\/buy-mounjaro-injectable-pen\/\">Mounjaro<\/a><\/th><th><a href=\"https:\/\/euslimstore.com\/wegovy-weight-loss-injection\/\">Wegovy<\/a><\/th><\/tr><\/thead><tbody><tr><td>Active ingredient<\/td><td>Tirzepatide<\/td><td>Semaglutide<\/td><\/tr><tr><td>Manufacturer<\/td><td>Eli Lilly<\/td><td>Novo Nordisk<\/td><\/tr><tr><td>Mechanism<\/td><td>Dual GLP-1 + GIP agonist<\/td><td>GLP-1 agonist (single hormone)<\/td><\/tr><tr><td>Average weight loss<\/td><td>22.5% over 72 weeks<\/td><td>21% over 68 weeks<\/td><\/tr><tr><td>Maximum dose<\/td><td>15 mg weekly<\/td><td>2.4 mg weekly<\/td><\/tr><tr><td>Frequency<\/td><td>Once weekly injection<\/td><td>Once weekly injection<\/td><\/tr><tr><td>Titration period<\/td><td>20 weeks<\/td><td>16 weeks<\/td><\/tr><tr><td>Cardiovascular benefit<\/td><td>Studies ongoing (SURMOUNT-MMO)<\/td><td>Confirmed 20% MACE reduction (SELECT)<\/td><\/tr><tr><td>Diabetes indication<\/td><td>Yes (also licensed for T2DM)<\/td><td>Only for diabetes if Ozempic (same molecule)<\/td><\/tr><tr><td>Starting price (EU Slim Store)<\/td><td>\u20ac148.00<\/td><td>\u20ac99.00<\/td><\/tr><tr><td>EMA approval (weight loss)<\/td><td>December 2023<\/td><td>January 2022<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">The 30-Second Summary<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Choose Mounjaro<\/strong> if you want maximum weight loss potential, have type 2 diabetes alongside obesity, haven&#8217;t achieved your goals on Wegovy, or have severe obesity (BMI \u2265 40).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Choose Wegovy<\/strong> if you have established cardiovascular disease (heart attack history, stroke history, or peripheral artery disease), want the most established long-term safety profile, want a slightly more affordable option, or are starting your first GLP-1 treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Both are excellent choices. Both will likely transform your weight and health. The differences matter at the margins but the overall fundamentals are similar \u2014 both produce substantially more weight loss than any other prescription option available in Europe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How Each Medication Works<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Mounjaro&#8217;s Dual-Hormone Mechanism<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/euslimstore.com\/buy-mounjaro-injectable-pen\/\">Mounjaro<\/a> contains <strong>tirzepatide<\/strong>, which mimics two natural gut hormones simultaneously:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>GLP-1 (glucagon-like peptide 1)<\/strong> \u2014 slows gastric emptying, reduces appetite signals in the brain, improves insulin response<\/li>\n\n\n\n<li><strong>GIP (glucose-dependent insulinotropic polypeptide)<\/strong> \u2014 enhances insulin secretion, improves adipose tissue insulin sensitivity, modulates appetite through different brain pathways<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This dual mechanism is why Mounjaro produces stronger weight loss than single-hormone GLP-1 agonists. The two hormones work synergistically \u2014 GLP-1 dominates appetite suppression while GIP enhances metabolic effects on fat tissue. The combination produces effects greater than the sum of each pathway alone.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tirzepatide was the first dual GLP-1\/GIP agonist ever approved for any medical use, originally licensed for type 2 diabetes (as Mounjaro) in late 2022 and subsequently for chronic weight management in December 2023.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Wegovy&#8217;s Single-Hormone Mechanism<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/euslimstore.com\/wegovy-weight-loss-injection\/\">Wegovy<\/a> contains <strong>semaglutide<\/strong>, which mimics only GLP-1. This still produces three coordinated effects:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Slowed gastric emptying \u2014 food remains in stomach longer, prolonging fullness<\/li>\n\n\n\n<li>Reduced appetite signals in hypothalamus and reward pathways \u2014 less hunger, less food-seeking<\/li>\n\n\n\n<li>Improved insulin response \u2014 stabilises blood sugar after meals<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Semaglutide has been studied extensively since the 1990s, originally approved for type 2 diabetes (as Ozempic) in 2017 and for chronic weight management (as Wegovy) in January 2022. Its safety and efficacy profile is the most thoroughly documented of any GLP-1 medication.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Effectiveness: How Much Weight Will You Actually Lose?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This is the most important question for most patients. The clinical trial data:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mounjaro Trial Data (SURMOUNT Program)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The pivotal SURMOUNT-1 trial enrolled 2,539 adults with obesity (BMI \u2265 30) or overweight (BMI \u2265 27 with comorbidities) without diabetes. Results at week 72:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>5 mg dose:<\/strong> 16.0% average weight loss<\/li>\n\n\n\n<li><strong>10 mg dose:<\/strong> 21.4% average weight loss<\/li>\n\n\n\n<li><strong>15 mg dose:<\/strong> 22.5% average weight loss (maximum)<\/li>\n\n\n\n<li><strong>Placebo:<\/strong> 2.4% weight loss<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">At the 15 mg dose, <strong>91% of patients lost at least 5% of body weight<\/strong>, 83% lost at least 10%, 63% lost at least 20%, and 36% lost at least 25%. These results are unprecedented for non-surgical weight loss medication.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Wegovy Trial Data (STEP Program)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The STEP-1 trial enrolled 1,961 adults with obesity or overweight with comorbidities. Results at week 68 with 2.4 mg dose:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wegovy 2.4 mg:<\/strong> 21.1% average weight loss<\/li>\n\n\n\n<li><strong>Placebo:<\/strong> 3.1% weight loss<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">86% of patients lost at least 5% of body weight, 69% lost at least 10%, 50% lost at least 15%, and 32% lost at least 20%. Strong but slightly less robust than Mounjaro 15 mg.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Head-to-Head: SURMOUNT-5<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">In 2024, the SURMOUNT-5 trial directly compared Mounjaro vs Wegovy. After 72 weeks of treatment in over 700 adults with obesity:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mounjaro (titrated to maximum tolerated dose):<\/strong> 20.2% average weight loss<\/li>\n\n\n\n<li><strong>Wegovy (titrated to maximum tolerated dose):<\/strong> 13.7% average weight loss<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The head-to-head result confirmed Mounjaro&#8217;s superior effectiveness \u2014 patients lost approximately 47% more weight on Mounjaro than on Wegovy in the same time period.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What This Means for Your Personal Decision<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">If maximum weight loss is your primary goal, Mounjaro has a clear advantage. However, both medications produce extraordinary results compared to anything else available. Wegovy&#8217;s 21% average is still nearly double what older medications like <a href=\"https:\/\/euslimstore.com\/buy-saxenda-weight-loss-pens-online\/\">Saxenda<\/a> achieved (8\u201312%), and triple what <a href=\"https:\/\/euslimstore.com\/xenical-orlistat-capsules\/\">Xenical<\/a> produces (5\u201310%).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you&#8217;re starting from a BMI of 35, Mounjaro&#8217;s ~22% average means losing about 24 kg from a 110 kg starting weight; Wegovy&#8217;s ~21% means losing about 23 kg. The practical difference is meaningful but not dramatic for most patients.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Cardiovascular Benefits: Where Wegovy Has the Edge<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This is one area where the comparison clearly favours Wegovy \u2014 at least for now. The <a href=\"https:\/\/sciencehub.novonordisk.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">SELECT trial<\/a> (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) enrolled over 17,000 patients with established cardiovascular disease and overweight\/obesity, randomising them to Wegovy or placebo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After approximately 3 years of treatment, Wegovy patients had:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>20% reduction<\/strong> in major adverse cardiovascular events (MACE) \u2014 cardiovascular death, non-fatal heart attack, or non-fatal stroke<\/li>\n\n\n\n<li><strong>15% reduction<\/strong> in all-cause mortality<\/li>\n\n\n\n<li><strong>19% reduction<\/strong> in cardiovascular mortality specifically<\/li>\n\n\n\n<li><strong>Significant reductions<\/strong> in heart failure events, kidney function decline, and progression to diabetes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">These outcomes were independent of the weight loss effects \u2014 meaning Wegovy provides cardiovascular protection beyond what weight loss alone explains.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For Mounjaro, the equivalent cardiovascular outcomes trial (SURMOUNT-MMO) is currently ongoing, with expected results in late 2027. Until then, Wegovy is the only weight loss medication with proven cardiovascular benefit specifically for non-diabetic patients with established heart disease.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Practical implication:<\/strong> If you have a history of heart attack, stroke, peripheral artery disease, or significant cardiovascular risk factors, Wegovy currently has stronger evidence supporting its use beyond just weight loss. Your doctor will weigh this when recommending between the two medications.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Side Effects: Comparable but Not Identical<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both medications cause similar gastrointestinal side effects, with broadly similar incidence rates. Direct comparison from the SURMOUNT-5 trial:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Side Effect<\/th><th>Mounjaro<\/th><th>Wegovy<\/th><\/tr><\/thead><tbody><tr><td>Nausea<\/td><td>44%<\/td><td>44%<\/td><\/tr><tr><td>Diarrhoea<\/td><td>27%<\/td><td>30%<\/td><\/tr><tr><td>Constipation<\/td><td>17%<\/td><td>24%<\/td><\/tr><tr><td>Vomiting<\/td><td>16%<\/td><td>24%<\/td><\/tr><tr><td>Discontinuation due to side effects<\/td><td>6%<\/td><td>8%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Notably, Mounjaro had slightly lower rates of vomiting and lower discontinuation due to side effects in the head-to-head comparison. This may reflect the dual GLP-1\/GIP mechanism \u2014 GIP appears to attenuate some of the gastric side effects that GLP-1 alone produces.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Side Effect Profile Differences in Practice<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Many patients report that the subjective experience of side effects differs between the two medications:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mounjaro<\/strong> users often report nausea is shorter in duration after each dose increase, but appetite suppression is more profound<\/li>\n\n\n\n<li><strong>Wegovy<\/strong> users often report more sustained mild nausea but easier transition between doses<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">These are general patterns with significant individual variation. Some patients tolerate one but not the other for unpredictable reasons. If side effects on one medication are intolerable, switching to the other often resolves the issue.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Dosing Schedules and Titration<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Mounjaro Titration Schedule<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Weeks 1\u20134:<\/strong> 2.5 mg weekly (starter, not therapeutic)<\/li>\n\n\n\n<li><strong>Weeks 5\u20138:<\/strong> 5 mg weekly (entry therapeutic)<\/li>\n\n\n\n<li><strong>Weeks 9\u201312:<\/strong> 7.5 mg weekly<\/li>\n\n\n\n<li><strong>Weeks 13\u201316:<\/strong> 10 mg weekly<\/li>\n\n\n\n<li><strong>Weeks 17\u201320:<\/strong> 12.5 mg weekly<\/li>\n\n\n\n<li><strong>Week 21+:<\/strong> 15 mg weekly (maximum maintenance)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Total titration: 20 weeks to reach maximum dose. Most patients reach the 10\u201315 mg range as their maintenance dose.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Wegovy Titration Schedule<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Weeks 1\u20134:<\/strong> 0.25 mg weekly (starter, not therapeutic)<\/li>\n\n\n\n<li><strong>Weeks 5\u20138:<\/strong> 0.5 mg weekly<\/li>\n\n\n\n<li><strong>Weeks 9\u201312:<\/strong> 1.0 mg weekly<\/li>\n\n\n\n<li><strong>Weeks 13\u201316:<\/strong> 1.7 mg weekly<\/li>\n\n\n\n<li><strong>Week 17+:<\/strong> 2.4 mg weekly (maintenance)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Total titration: 16 weeks to reach maintenance dose. All patients reach the same 2.4 mg maintenance dose.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Implications<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Wegovy reaches its maintenance dose 4 weeks faster than Mounjaro. However, Mounjaro offers more dose flexibility \u2014 patients can stop titrating at 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg depending on their response and tolerance. Wegovy is essentially binary at maintenance \u2014 either 2.4 mg or step down.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For patients sensitive to side effects, Mounjaro&#8217;s gradual dose escalation provides more opportunities to optimise the balance between effectiveness and tolerability.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contraindications: Who Cannot Take Each Medication<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The contraindications for Mounjaro and Wegovy are nearly identical, reflecting their shared pharmacological class:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Absolute Contraindications (Both Medications)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Personal or family history of medullary thyroid carcinoma (MTC)<\/li>\n\n\n\n<li>Multiple endocrine neoplasia syndrome type 2 (MEN 2)<\/li>\n\n\n\n<li>Pregnancy or active breastfeeding<\/li>\n\n\n\n<li>Severe gastrointestinal disease (gastroparesis, severe GERD, history of intestinal obstruction)<\/li>\n\n\n\n<li>Active pancreatitis or history of recurrent pancreatitis<\/li>\n\n\n\n<li>Type 1 diabetes (these medications don&#8217;t substitute for insulin)<\/li>\n\n\n\n<li>Diabetic ketoacidosis<\/li>\n\n\n\n<li>Known severe allergic reaction to GLP-1 agonists<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Relative Contraindications<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Moderate-to-severe diabetic retinopathy (Wegovy specifically requires caution)<\/li>\n\n\n\n<li>Severe gastroparesis<\/li>\n\n\n\n<li>History of bariatric surgery<\/li>\n\n\n\n<li>Severe chronic kidney disease (CKD stages 4\u20135)<\/li>\n\n\n\n<li>Patients planning pregnancy within 2 months<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">If you have any of these conditions, your reviewing doctor will need to weigh risks and benefits carefully. For most patients with typical obesity (without rare medical issues), neither Mounjaro nor Wegovy is contraindicated.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Costs: Price Comparison Across Markets<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pricing varies significantly across European markets and online pharmacies. EU Slim Store offers transparent all-inclusive pricing:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">EU Slim Store Pricing<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/euslimstore.com\/wegovy-weight-loss-injection\/\">Wegovy<\/a>:<\/strong> Starting at \u20ac99.00 (for starter dose pen, contains 4 weekly doses at your prescribed strength)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/euslimstore.com\/buy-mounjaro-injectable-pen\/\">Mounjaro<\/a>:<\/strong> Starting at \u20ac148.00 (per single-use weekly pen)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">All-inclusive pricing covers the medication, free doctor consultation, pharmacy dispensing, ongoing patient support, and discreet temperature-controlled delivery.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Long-Term Cost Comparison<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Comparing 12-month treatment costs at maintenance doses (rough estimates, actual costs vary based on prescribed dose):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wegovy 12-month maintenance:<\/strong> \u20ac99.00\u2013\u20ac280.00 per month \u00d7 12 = approximately \u20ac1,188\u2013\u20ac3,360<\/li>\n\n\n\n<li><strong>Mounjaro 12-month maintenance:<\/strong> \u20ac148.00\u2013\u20ac298.00 per month \u00d7 12 = approximately \u20ac1,776\u2013\u20ac3,576<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mounjaro is approximately 15\u201325% more expensive over a full year of treatment. For maximum weight loss outcomes, many patients consider this differential worthwhile.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Insurance Coverage Reality<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Across most European markets, neither Mounjaro nor Wegovy is reliably covered by basic health insurance for weight management indications. Coverage for type 2 diabetes use varies by country and insurance scheme. Most patients pay privately for weight loss treatment with either medication.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Choosing for Specific Situations<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">You Have Type 2 Diabetes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Both Mounjaro and Wegovy (sold as <a href=\"https:\/\/euslimstore.com\/ozempic-semaglutide-for-type-2-diabetes-injection\/\">Ozempic<\/a> for diabetes indication) effectively manage type 2 diabetes. Mounjaro is generally more effective for both glycemic control and weight loss in diabetic patients. If you have both diabetes and obesity, Mounjaro is often the better choice.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You Have Cardiovascular Disease<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Wegovy currently has proven cardiovascular outcome benefits (20% MACE reduction) that Mounjaro hasn&#8217;t yet demonstrated (trial ongoing). For patients with established heart disease, stroke history, or peripheral artery disease, Wegovy is the better-evidenced choice in 2026.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You&#8217;re Starting Your First Weight Loss Medication<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Either is a reasonable choice. Wegovy is slightly more affordable and has the more established safety profile. Mounjaro offers higher weight loss potential. Many patients start with Wegovy and switch to Mounjaro if outcomes are insufficient, or vice versa.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You&#8217;ve Already Tried One and Plateaued<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">If you&#8217;ve achieved good weight loss on Wegovy but plateaued, switching to Mounjaro often produces additional weight loss (5\u201310% beyond your Wegovy plateau in many cases). If you&#8217;ve struggled on Mounjaro due to side effects, switching to Wegovy may work better despite potentially lower maximum weight loss.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You Have Severe Obesity (BMI \u2265 40)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">For severe obesity, Mounjaro&#8217;s higher weight loss potential is meaningful. Losing 22% of body weight from a starting weight of 130 kg means losing approximately 29 kg, versus 27 kg with Wegovy \u2014 a 2 kg difference that may matter clinically for comorbidity improvement.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You Have Limited Budget<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Wegovy is the more affordable option at \u20ac99 starting vs Mounjaro&#8217;s \u20ac148. If maximum weight loss isn&#8217;t your absolute priority and Wegovy&#8217;s outcomes are sufficient for your goals, the cost difference is meaningful.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">You Want the Most Established Safety Profile<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Wegovy has been licensed since 2022, with the underlying semaglutide molecule extending back to Ozempic&#8217;s approval in 2017 \u2014 about 8 years of cumulative real-world experience by 2026. Mounjaro has been approved for weight loss since December 2023 (about 2.5 years by mid-2026). Both have excellent safety profiles, but Wegovy has more cumulative data.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Switching Between Mounjaro and Wegovy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Many patients switch between these medications during their treatment journey. Switching is straightforward but should always be done with doctor guidance:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Wegovy \u2192 Mounjaro<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Typical reason: Plateau on Wegovy, want more weight loss. Approach: Stop Wegovy. Start Mounjaro at 2.5 mg (starter dose). Re-titrate through the Mounjaro schedule. Total transition takes about 20 weeks to reach Mounjaro maintenance.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mounjaro \u2192 Wegovy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Typical reason: Mounjaro side effects intolerable, cost concerns, or desire for cardiovascular outcomes. Approach: Stop Mounjaro. Start Wegovy at 0.25 mg (starter dose). Re-titrate through Wegovy schedule. Total transition takes about 16 weeks to reach Wegovy maintenance.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Why Re-Titration Is Necessary<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Even though both medications are GLP-1 agonists, the doses aren&#8217;t directly equivalent. Starting at maintenance dose of the new medication risks severe side effects. Re-titration allows the body to adapt to the new molecule.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Real Patients Report About Each<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">From thousands of patient experiences with both medications:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Common Mounjaro Patient Reports<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>&#8220;My hunger virtually disappeared. I have to remind myself to eat.&#8221;<\/li>\n\n\n\n<li>&#8220;The food noise stopped. I no longer think about food constantly.&#8221;<\/li>\n\n\n\n<li>&#8220;Side effects were worst at the 5 mg step. Smooth after that.&#8221;<\/li>\n\n\n\n<li>&#8220;I&#8217;m losing 1\u20131.5 kg per week consistently.&#8221;<\/li>\n\n\n\n<li>&#8220;My energy is better than it&#8217;s been in years.&#8221;<\/li>\n\n\n\n<li>&#8220;Cravings for sugar and carbs are gone. I can&#8217;t believe it.&#8221;<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Common Wegovy Patient Reports<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>&#8220;My relationship with food has fundamentally changed.&#8221;<\/li>\n\n\n\n<li>&#8220;I needed to learn to eat enough \u2014 fullness comes so fast.&#8221;<\/li>\n\n\n\n<li>&#8220;Nausea was tough during titration but manageable with smaller meals.&#8221;<\/li>\n\n\n\n<li>&#8220;I&#8217;m down 18 kg in 8 months and still losing.&#8221;<\/li>\n\n\n\n<li>&#8220;My blood pressure improved within 6 weeks.&#8221;<\/li>\n\n\n\n<li>&#8220;I feel like my body is finally working properly.&#8221;<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Common Frustrations on Both<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Plateau periods where weight loss slows or stalls temporarily<\/li>\n\n\n\n<li>Need to consciously eat enough protein (especially during peak appetite suppression)<\/li>\n\n\n\n<li>Sleep disruption from gastrointestinal side effects during titration<\/li>\n\n\n\n<li>Adjusting social eating habits when food doesn&#8217;t appeal<\/li>\n\n\n\n<li>Family\/friends asking about visible weight loss<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Combining With Lifestyle Changes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both Mounjaro and Wegovy work best combined with lifestyle changes:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Diet During Treatment<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Protein priority<\/strong> \u2014 1.2\u20131.6 g per kg of body weight daily; essential for preserving muscle during weight loss<\/li>\n\n\n\n<li><strong>Adequate hydration<\/strong> \u2014 at least 2L water daily; reduces nausea and supports metabolism<\/li>\n\n\n\n<li><strong>Smaller meals<\/strong> \u2014 eat less per sitting but more frequently to manage fullness<\/li>\n\n\n\n<li><strong>Avoid greasy\/fried foods<\/strong> \u2014 particularly during titration; these substantially worsen nausea<\/li>\n\n\n\n<li><strong>Whole foods focus<\/strong> \u2014 vegetables, fruits, lean proteins, whole grains<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Exercise During Treatment<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Resistance training<\/strong> 2\u20133x weekly \u2014 preserves muscle mass during rapid weight loss<\/li>\n\n\n\n<li><strong>Moderate cardio<\/strong> 150+ minutes weekly \u2014 supports cardiovascular health and energy<\/li>\n\n\n\n<li><strong>Walking<\/strong> \u2014 easy, low-impact, surprisingly effective for metabolic health<\/li>\n\n\n\n<li><strong>Flexibility\/mobility work<\/strong> \u2014 important as your body composition changes<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Sleep and Stress Management<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Both medications work better when patients prioritise sleep (7\u20139 hours nightly) and manage stress. Cortisol from chronic stress can blunt weight loss; poor sleep affects hunger hormones independent of medication effects.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">When Either Medication Isn&#8217;t Right<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">If neither Mounjaro nor Wegovy works for you (due to contraindications, intolerable side effects, or insufficient response), other options exist:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/euslimstore.com\/buy-saxenda-weight-loss-pens-online\/\">Saxenda<\/a><\/strong> (liraglutide) \u2014 daily GLP-1 injection, smaller average weight loss (8\u201312%) but established safety<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/euslimstore.com\/buy-biolide-liraglutide-weight-loss-pen\/\">Biolide<\/a> \/ <a href=\"https:\/\/euslimstore.com\/nevolat-daily-injection-liraglutide-weight-loss-pen\/\">Nevolat<\/a> \/ <a href=\"https:\/\/euslimstore.com\/plaobes-daily-injection\/\">Plaobes<\/a><\/strong> \u2014 daily liraglutide alternatives at lower price points<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/euslimstore.com\/buy-wegovy-pills-online-europe\/\">Wegovy Pills<\/a><\/strong> \u2014 oral semaglutide for patients who prefer tablets to injections<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/euslimstore.com\/mysimba-naltrexone-bupropion-weight-loss-tablets\/\">Mysimba<\/a><\/strong> \u2014 different mechanism (brain reward modulation), 5\u20139% average weight loss<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/euslimstore.com\/xenical-orlistat-capsules\/\">Xenical<\/a><\/strong> \u2014 fat-absorption blocker, 5\u201310% weight loss, oldest established prescription weight loss medication<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Practical Decision Framework<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">If you&#8217;re still unsure which medication to choose, use this decision framework:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Start with Mounjaro if:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>You want the maximum possible weight loss<\/li>\n\n\n\n<li>You have type 2 diabetes alongside obesity<\/li>\n\n\n\n<li>You have severe obesity (BMI \u2265 40)<\/li>\n\n\n\n<li>You can afford the slightly higher cost<\/li>\n\n\n\n<li>You don&#8217;t have established cardiovascular disease where Wegovy&#8217;s outcome data matters<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Start with Wegovy if:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>You have cardiovascular disease or significant cardiovascular risk factors<\/li>\n\n\n\n<li>You want the most established long-term safety profile<\/li>\n\n\n\n<li>Cost is a meaningful consideration<\/li>\n\n\n\n<li>You&#8217;re new to GLP-1 treatment and want a well-understood starting point<\/li>\n\n\n\n<li>You don&#8217;t need the absolute maximum weight loss<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Get personalised guidance:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ultimately, this decision is best made with input from a qualified doctor reviewing your specific medical profile. Our <a href=\"https:\/\/euslimstore.com\/weight-loss-consultation\/\">free online consultation<\/a> provides exactly this \u2014 a Dutch BIG-registered or GPhC-affiliated physician will review your case within 24 hours and recommend the medication that fits your situation best.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n<div id=sp-eap-accordion-section-2061 class=\"sp-eap-container\"><h2 class=\"eap_section_title_2061\"> Blog Post 4: Mounjaro vs Wegovy 2026 FAQs <\/h2>\t<div id=\"eap_faq_search_bar_container\">\n\t\t<input type=\"search\"  data-shortcode-id=\"2061\" data-autocomplete=\"\" name=\"eap_faq_search_bar_sp-ea\" id=\"eap_faq_search_bar_sp-ea-2061\" placeholder=\"Search your FAQ\" value=\"\" onkeyup=\"this.setAttribute('value', this.value);\">\n\t\t<a><\/a>\n\t<\/div>\n\t<div id=\"sp-ea-2061\" class=\"sp-ea-five ea-icon-style-three sp-easy-accordion\" data-ex-icon=\"fa-minus\" data-col-icon=\"fa-plus\"  data-ea-active=\"ea-click\"  data-ea-mode=\"vertical\" data-ea-coll=\"\" data-keep-accordion=\"\" data-autoclose=\"\" data-preloader=\"\" data-autoplaytime=\"3000\" data-expand=>\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20610&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20610\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Which is more effective for weight loss: Mounjaro or Wegovy?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20610\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Mounjaro produces more weight loss on average. The SURMOUNT-5 head-to-head trial showed Mounjaro produced 20.2% average weight loss vs 13.7% for Wegovy over 72 weeks \u2014 approximately 47% more weight loss on Mounjaro. Individual results vary, but the clinical evidence consistently shows Mounjaro's slight advantage for maximum weight loss potential due to its dual GLP-1\/GIP mechanism.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20611&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20611\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Why does Mounjaro work better than Wegovy?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20611\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Mounjaro (tirzepatide) targets two hormones simultaneously \u2014 GLP-1 and GIP \u2014 while Wegovy (semaglutide) targets only GLP-1. The dual-hormone mechanism produces synergistic effects: GLP-1 dominates appetite suppression while GIP enhances insulin sensitivity in fat tissue and modulates appetite through different brain pathways. The combination produces stronger effects than the sum of each pathway alone.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20612&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20612\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Is Mounjaro safer than Wegovy or vice versa?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20612\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Both medications have similar safety profiles. Wegovy has more cumulative safety data (semaglutide approved since 2017 as Ozempic, 2022 as Wegovy) vs Mounjaro (tirzepatide approved for diabetes in 2022, for weight loss in late 2023). Both are well-tolerated by most patients. Direct comparison from SURMOUNT-5 showed slightly lower discontinuation due to side effects on Mounjaro (6% vs 8% on Wegovy).<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20613&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20613\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Does Mounjaro or Wegovy have better cardiovascular benefits?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20613\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Wegovy currently has stronger cardiovascular evidence. The SELECT trial showed Wegovy reduced major adverse cardiovascular events by 20% in patients with established heart disease. Mounjaro's equivalent cardiovascular outcomes trial (SURMOUNT-MMO) is ongoing with results expected late 2027. For patients with established cardiovascular disease, Wegovy is currently the better-evidenced choice.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20614&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20614\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Should I choose Mounjaro or Wegovy for type 2 diabetes?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20614\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Mounjaro is generally more effective for both glycemic control and weight loss in diabetic patients. It produces stronger HbA1c reductions and superior weight outcomes compared to semaglutide (Ozempic or Wegovy). If you have both type 2 diabetes and obesity, Mounjaro is often the better choice. Your doctor will consider your full clinical profile, including cardiovascular history.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20615&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20615\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Mounjaro vs Wegovy: which has worse side effects?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20615\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Side effect profiles are similar but not identical. Both cause primarily gastrointestinal effects (nausea, diarrhoea, constipation). In direct comparison: Mounjaro had slightly lower rates of vomiting and constipation than Wegovy. Discontinuation due to side effects was lower on Mounjaro (6%) than Wegovy (8%). Individual experience varies \u2014 some patients tolerate one but not the other unpredictably.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20616&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20616\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  How long does it take to reach the maintenance dose on Mounjaro vs Wegovy?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20616\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Wegovy reaches its maintenance dose faster: 16 weeks total titration through 5 dose steps (0.25 \u2192 0.5 \u2192 1.0 \u2192 1.7 \u2192 2.4 mg). Mounjaro takes 20 weeks total titration through 6 dose steps (2.5 \u2192 5 \u2192 7.5 \u2192 10 \u2192 12.5 \u2192 15 mg). Mounjaro offers more dose flexibility \u2014 patients can stop at intermediate doses based on response.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20617&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20617\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Can I switch from Wegovy to Mounjaro or vice versa?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20617\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Yes \u2014 many patients switch between these medications. Common reasons: plateau on one medication wanting more weight loss, intolerable side effects, cost considerations, or wanting cardiovascular outcome benefits. Switching requires stopping the current medication and re-titrating from the starter dose of the new medication. Total transition takes 16-20 weeks to reach the new maintenance dose.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20618&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20618\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Is Mounjaro worth the higher cost compared to Wegovy?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20618\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>It depends on your priorities. Mounjaro is approximately 15-25% more expensive over 12 months (\u20ac148+ starting vs \u20ac99+ for Wegovy) but produces approximately 47% more weight loss in head-to-head trials. For patients prioritising maximum weight loss, the cost differential is often justified. For patients with cardiovascular concerns where Wegovy's outcome data matters, Wegovy may be more valuable despite less weight loss.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq20619&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse20619\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Do Mounjaro and Wegovy have the same contraindications?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse20619\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Yes \u2014 the contraindications are essentially identical: personal\/family history of medullary thyroid carcinoma (MTC), MEN 2 syndrome, pregnancy\/breastfeeding, severe gastrointestinal disease, active or recurrent pancreatitis, type 1 diabetes, diabetic ketoacidosis, severe allergic reaction to GLP-1 agonists. Both medications belong to the same pharmacological class with the same safety considerations.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq206110&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse206110\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  What if neither Mounjaro nor Wegovy works for me?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse206110\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>Other options exist: Saxenda (daily liraglutide, lower potency but well-established), Biolide\/Nevolat\/Plaobes (affordable daily liraglutide alternatives), Wegovy Pills (oral semaglutide for patients preferring tablets), Mysimba (different mechanism targeting brain reward), or Xenical (fat-absorption blocker). Your doctor can guide selection based on why the GLP-1 injections weren't suitable for you.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t\t<div class=\"ea-card   sp-ea-single\" id=&quot;esp_faq206111&quot; >\n\n\t\t<h3 class=\"ea-header\">\n\t\t\t<a class=\"collapsed\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse206111\" href=\"javascript:void(0)\" aria-expanded=\"false\">\n\t\t\t\t<i class=\"ea-expand-icon fa fa-plus\"><\/i>  Can I take Mounjaro and Wegovy together?\t\t\t<\/a>\n\t\t<\/h3>\n\n\t\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse206111\" data-parent=\"#sp-ea-2061\">\n\t\t\t<div class=\"ea-body animated fadeIn\"> <p>No \u2014 both medications are GLP-1 receptor agonists with overlapping effects. Combining them would not produce additional weight loss but would substantially increase side effects and risk. Patients on one of these medications should not take the other simultaneously. If your current treatment isn't producing sufficient results, switch to the other under doctor guidance rather than combining.<\/p>\n <\/div>\t\t<\/div>\n\t<\/div>\n\t<\/div><script type=\"application\/ld+json\">\n\t{\n\t  \"@context\": \"https:\/\/schema.org\",\n\t  \"@type\": \"FAQPage\",\n\t  \"mainEntity\": [{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Which is more effective for weight loss: Mounjaro or Wegovy?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Mounjaro produces more weight loss on average. The SURMOUNT-5 head-to-head trial showed Mounjaro produced 20.2% average weight loss vs 13.7% for Wegovy over 72 weeks \u2014 approximately 47% more weight loss on Mounjaro. Individual results vary, but the clinical evidence consistently shows Mounjaro's slight advantage for maximum weight loss potential due to its dual GLP-1\/GIP mechanism.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Why does Mounjaro work better than Wegovy?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Mounjaro (tirzepatide) targets two hormones simultaneously \u2014 GLP-1 and GIP \u2014 while Wegovy (semaglutide) targets only GLP-1. The dual-hormone mechanism produces synergistic effects: GLP-1 dominates appetite suppression while GIP enhances insulin sensitivity in fat tissue and modulates appetite through different brain pathways. The combination produces stronger effects than the sum of each pathway alone.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Is Mounjaro safer than Wegovy or vice versa?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Both medications have similar safety profiles. Wegovy has more cumulative safety data (semaglutide approved since 2017 as Ozempic, 2022 as Wegovy) vs Mounjaro (tirzepatide approved for diabetes in 2022, for weight loss in late 2023). Both are well-tolerated by most patients. Direct comparison from SURMOUNT-5 showed slightly lower discontinuation due to side effects on Mounjaro (6% vs 8% on Wegovy).\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Does Mounjaro or Wegovy have better cardiovascular benefits?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Wegovy currently has stronger cardiovascular evidence. The SELECT trial showed Wegovy reduced major adverse cardiovascular events by 20% in patients with established heart disease. Mounjaro's equivalent cardiovascular outcomes trial (SURMOUNT-MMO) is ongoing with results expected late 2027. For patients with established cardiovascular disease, Wegovy is currently the better-evidenced choice.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Should I choose Mounjaro or Wegovy for type 2 diabetes?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Mounjaro is generally more effective for both glycemic control and weight loss in diabetic patients. It produces stronger HbA1c reductions and superior weight outcomes compared to semaglutide (Ozempic or Wegovy). If you have both type 2 diabetes and obesity, Mounjaro is often the better choice. Your doctor will consider your full clinical profile, including cardiovascular history.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Mounjaro vs Wegovy: which has worse side effects?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Side effect profiles are similar but not identical. Both cause primarily gastrointestinal effects (nausea, diarrhoea, constipation). In direct comparison: Mounjaro had slightly lower rates of vomiting and constipation than Wegovy. Discontinuation due to side effects was lower on Mounjaro (6%) than Wegovy (8%). Individual experience varies \u2014 some patients tolerate one but not the other unpredictably.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"How long does it take to reach the maintenance dose on Mounjaro vs Wegovy?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Wegovy reaches its maintenance dose faster: 16 weeks total titration through 5 dose steps (0.25 \u2192 0.5 \u2192 1.0 \u2192 1.7 \u2192 2.4 mg). Mounjaro takes 20 weeks total titration through 6 dose steps (2.5 \u2192 5 \u2192 7.5 \u2192 10 \u2192 12.5 \u2192 15 mg). Mounjaro offers more dose flexibility \u2014 patients can stop at intermediate doses based on response.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Can I switch from Wegovy to Mounjaro or vice versa?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Yes \u2014 many patients switch between these medications. Common reasons: plateau on one medication wanting more weight loss, intolerable side effects, cost considerations, or wanting cardiovascular outcome benefits. Switching requires stopping the current medication and re-titrating from the starter dose of the new medication. Total transition takes 16-20 weeks to reach the new maintenance dose.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Is Mounjaro worth the higher cost compared to Wegovy?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"It depends on your priorities. Mounjaro is approximately 15-25% more expensive over 12 months (\u20ac148+ starting vs \u20ac99+ for Wegovy) but produces approximately 47% more weight loss in head-to-head trials. For patients prioritising maximum weight loss, the cost differential is often justified. For patients with cardiovascular concerns where Wegovy's outcome data matters, Wegovy may be more valuable despite less weight loss.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Do Mounjaro and Wegovy have the same contraindications?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Yes \u2014 the contraindications are essentially identical: personal\/family history of medullary thyroid carcinoma (MTC), MEN 2 syndrome, pregnancy\/breastfeeding, severe gastrointestinal disease, active or recurrent pancreatitis, type 1 diabetes, diabetic ketoacidosis, severe allergic reaction to GLP-1 agonists. Both medications belong to the same pharmacological class with the same safety considerations.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"What if neither Mounjaro nor Wegovy works for me?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"Other options exist: Saxenda (daily liraglutide, lower potency but well-established), Biolide\/Nevolat\/Plaobes (affordable daily liraglutide alternatives), Wegovy Pills (oral semaglutide for patients preferring tablets), Mysimba (different mechanism targeting brain reward), or Xenical (fat-absorption blocker). Your doctor can guide selection based on why the GLP-1 injections weren't suitable for you.\"\n\t\t\t}\n\t\t},{\n\t\t\t\"@type\": \"Question\",\n\t\t\t\"name\": \"Can I take Mounjaro and Wegovy together?\", \n\t\t\t\"acceptedAnswer\": {\n\t\t\t  \"@type\": \"Answer\",\n\t\t\t  \"text\": \"No \u2014 both medications are GLP-1 receptor agonists with overlapping effects. Combining them would not produce additional weight loss but would substantially increase side effects and risk. Patients on one of these medications should not take the other simultaneously. If your current treatment isn't producing sufficient results, switch to the other under doctor guidance rather than combining.\"\n\t\t\t}\n\t\t}]\n\t}\n\t<\/script><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">Ready to Start Treatment?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both Mounjaro and Wegovy will likely produce more weight loss than you&#8217;ve achieved through any other method. The &#8220;wrong&#8221; choice between them is still likely to be a substantially better outcome than no treatment at all. Don&#8217;t let analysis paralysis prevent you from starting.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Next steps:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/euslimstore.com\/body-mass-index-calculator\/\">Check your BMI<\/a> to confirm eligibility (both medications require BMI \u2265 30, or \u2265 27 with comorbidities)<\/li>\n\n\n\n<li>Review product details: <a href=\"https:\/\/euslimstore.com\/buy-mounjaro-injectable-pen\/\">Mounjaro<\/a> or <a href=\"https:\/\/euslimstore.com\/wegovy-weight-loss-injection\/\">Wegovy<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/euslimstore.com\/weight-loss-consultation\/\">Start your free online consultation<\/a> \u2014 doctor reviews your case within 24 hours and recommends the best medication for your situation<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For more context on the broader prescription weight loss landscape, see our <a href=\"\/buy-weight-loss-injections-europe-guide-2026\/\">complete 2026 guide to buying weight loss injections in Europe<\/a>. For Netherlands-specific guidance, see <a href=\"\/buy-wegovy-netherlands-online-guide\/\">Where to Buy Wegovy in the Netherlands<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you want to ensure you&#8217;re buying from a legitimate source rather than counterfeit operations, read our essential safety guide: <a href=\"\/safe-buy-weight-loss-injections-online-counterfeit-guide\/\">Buying Weight Loss Injections Online: Legitimate vs Counterfeit<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Updated June 2026. The definitive side-by-side comparison of the two most effective prescription weight loss medications in Europe \u2014 tirzepatide vs semaglutide \u2014 covering effectiveness, side effects, costs, contraindications, dosing schedules, cardiovascular benefits, and clinical evidence to help you choose the right treatment. If you&#8217;re considering prescription weight loss treatment in 2026, you&#8217;re almost certainly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2071,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"categories":[428],"tags":[],"class_list":["post-2070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-weight-loss"],"_links":{"self":[{"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/posts\/2070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/comments?post=2070"}],"version-history":[{"count":1,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/posts\/2070\/revisions"}],"predecessor-version":[{"id":2072,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/posts\/2070\/revisions\/2072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/media\/2071"}],"wp:attachment":[{"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/media?parent=2070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/categories?post=2070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/euslimstore.com\/fr\/wp-json\/wp\/v2\/tags?post=2070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}